LBF20406LT10: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
|LipidMaps=LMFA03020017 | |LipidMaps=LMFA03020017 | ||
|SysName=5S,12R-dihydroxy-6Z,8E,10E-eicosatriene-14-ynoic acid | |SysName=5S,12R-dihydroxy-6Z,8E,10E-eicosatriene-14-ynoic acid | ||
|Common Name=&&14,15-dehydro Leukotriene B4 | |Common Name=&&14,15-dehydro Leukotriene B4&& | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= |
Revision as of 06:00, 15 April 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR3119 |
LipidMaps | LMFA03020017 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20406LT10 |
14,15-dehydro Leukotriene B4 | |
---|---|
Structural Information | |
5S,12R-dihydroxy-6Z,8E,10E-eicosatriene-14-ynoic acid | |
| |
Formula | C20H30O4 |
Exact Mass | 334.21440944799997 |
Average Mass | 334.4498 |
SMILES | C(CC#CC[C@H](C=CC=CC=C[C@H](CCCC(O)=O)O)O)CCC |
Physicochemical Information | |
14,15-dehydro LTB4 is reported as a selective ligand for the BLT1 and act as a selective antagonist of LTB4 in vivo. Wang_S et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|